FDA Panel Rejects Psychedelic Drug MDMA to Treat PTSD

A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday – a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical…

Read Full Article (External Site)